We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PCVX market cap is 11.01B. The company's latest EPS is USD -3.2275 and P/E is -27.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -113.03M | -196.68M | -114.47M | -152.98M | -139.92M |
| Net Income | -92.66M | -180.8M | -95.02M | -128.7M | -103.13M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -89.58M | -103.67M | -232.26M | -468.04M |
| Net Income | -89.22M | -100.08M | -223.49M | -402.27M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 1.5B | 1.41B | 2.09B | 2.09B | 3.56B |
| Total Liabilities | 93.34M | 167.45M | 107.32M | 101.14M | 142.11M |
| Total Equity | 1.4B | 1.24B | 1.98B | 1.99B | 3.42B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 392.83M | 324.34M | 1.01B | 1.41B |
| Total Liabilities | 46.98M | 40.32M | 52.57M | 167.45M |
| Total Equity | 345.84M | 284.02M | 953.61M | 1.24B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -167.98M | -296.79M | -159.12M | -280.52M | -341.23M |
| Investing | -759.39M | -773.31M | -451.07M | -531.48M | -1.45B |
| Financing | 637.08M | 639.81M | 818.2M | 928.56M | 2.44B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -46.63M | -121.39M | -170.6M | -296.79M |
| Investing | -1.11M | -212.31M | 74.59M | -773.31M |
| Financing | 374.87M | 17.8M | 861.55M | 639.81M |
| Market Cap | 11.01B |
| Price to Earnings Ratio | -27.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.73 |
| Price to Book Ratio | 8.88 |
| Dividend Yield | - |
| Shares Outstanding | 124.64M |
| Average Volume (1 week) | 986.82k |
| Average Volume (1 Month) | 1.27M |
| 52 Week Change | 25.10% |
| 52 Week High | 121.055 |
| 52 Week Low | 58.10 |
| Spread (Intraday) | 11.39 (11.46%) |
| Company Name | Vaxcyte Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vaxcyte.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
